ARCUS BIOSCIENCES, INC.
Last · NYSE$22.53+0.02 (+0.09%)close · yahoo · 15h ago
Vol 1.21M ≈ 27.31M
MA10MA20MA50
Market cap$2.87B127.3M sh
P/E · TTM-5.8fwd -7.1 · eps -3.91 · loss
Beta0.94vs S&P 500
Div yield0.00%annual · TTM
52w range
$15.38$31.73
Volume1.2Msession
Issuer
Legal nameARCUS BIOSCIENCES, INC.
HQUnited States (US)
ListingUS RCUS
ISINUS03969F1093
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001724521
CIK0001724521
Websitearcusbio.com
Employees601
AddressArcus Biosciences, Inc. 3928 Point Eden Way 94545, Hayward
| Revenue | $40.0M |
|---|---|
| Operating income | $-230.0M |
| Net income | $-219.0M |
| Free cash flow | $-257.0M |
| Operating margin | -575.0% |
| Net margin | -547.5% |
| Return on equity | -47.2% |
| Period | 2026 |
Loading chart…
Upcoming earnings
TUE.27OCT
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.87
Est. revenue
11.9M
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 5 filings